Off-label use catalogue of tumor anti-angiogenic drugs in China: a narrative review

BackgroundThe management of off-label use (OLU) is an important aspect of standardizing and promoting the rational use of antitumor drugs. Tumor anti-angiogenic therapy (AAT) is essential in cancer treatment. However, OLU of anti-angiogenic drugs is common in clinical practice. Recognizing and stand...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Difei Yao, Yangmin Hu, Shanshan Weng, Tiantian Wang, Tao Zhu, Lulu Liu, Huan Luo, Wei He, Haibin Dai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-10-01
Subjects:	anti-angiogenic therapy off-label use drug label guidelines drug management
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1668620/full